Pooled analysis of multiple crossover trials to optimize individual therapy response to renin-angiotensin-aldosterone system intervention
Clinical Journal of the American Society of Nephrology | Oct 17, 2017
Petrykiv SI, et al. - This study investigated if uptitrating the dose of drug, changing the mode of intervention (with drugs from similar or different classes), or lowering dietary sodium intake, therapy resistance to renin-angiotensin-aldosterone system inhibitors (RAASi) can be overcome. For this purpose, researchers meta-analyzed individual responses to different modes of interventions. Findings demonstrated that those who exhibited a poor response to one dose or type of RAASi also responded poorly to higher doses, other types of RAASi or nonsteroidal anti-inflammatory drugs (NSAIDs), or a reduction in dietary salt intake.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries